Search

Fight for Firewalls: HIV and Health Data Privacy in the Snowballing Surveillance State

1st International Workshop on Long Acting Anti-Infectives (LAAI) 2025

World Health Assembly-A new era of HIV prevention; Accelerating access to long-acting prevention options through sustainable prevention systems and financing

HIV Vaccine Awareness Day 2025

HVAD 2025 comes as the US presidential administration is actively working to dismantle HIV research and demolish the architecture of global health. The entire HIV response — from basic research and clinical development to policy, programs, and global access to life-saving treatment and prevention — is now under attack, and the world runs the risk of reversing the strides made to end HIV.

Global Health Watch: FY26 Proposed Budget, WHO Leadership Changes and New AVAC Resources

This week’s issue covers the Secretary of Health and Human Services’ defense of deep NIH budget cuts before Congress, leadership changes at WHO, and the latest update in AVAC’s lawsuit attempting to halt the US foreign aid freeze.

Protect Federal Funding for HIV, TB, and STI Research and Prevention at the National Institutes of Health

AVAC and 627 organizations, institutions, researchers, clinicians, public health advocates and stakeholders submitted a written letter to the Senate HELP Committee urging lawmakers to reject the cuts to NIH funding for HIV, TB, and STI research and highlighting the impact of these cuts on lifesaving innovation and research infrastructure.

100 Days In: How HIV Advocates are Meeting the Moment

The Scientific Journey of Lenacapavir: From basic science to clinical development to impact

HIV Prevention R&D at Risk

AVAC’s analysis of the impact of US Government funding cuts, terminated projects, and other policy changes on the HIV prevention research and development (R&D) pipeline, and on HIV research broadly.

HIV Prevention at a Crossroads: Why we still need an HIV vaccine